Back to search

Article

Isorhapontigenin is a novel potential therapeutic agent for lung cancer: evidence from network pharmacology, bioinformatics, molecular docking and in vitro experiments

2025-02-04

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Isorhapontigenin is an effective active ingredient in rheum officinale, which has been reported to have anti-tumor effects. However, its effect and molecular mechanism on non-small cell lung cancer are still unclear. <bold>Methods</bold>: Firstly, potential therapeutic targets of Isorhapontigenin against non-small cell lung cancer were obtained through network p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c68dcbc-38b3-5750-98b4-4f7c99a9ed2d
DOI
10.21203/rs.3.rs-5882443/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Isorhapontigenin is a novel potential therapeutic agent for lung cancer: evidence from network pharmacology, bioinformatics, molecular docking and in vitro experimentsDOI 10.21203/rs.3.rs-5882443/v1
Select a neighboring publication to make it the new centre.